Boudreau Philip P (CIK 1805099) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-03). Recent activity: Sell ABT (388 shares), Buy ABT (8,909 shares), Buy ABT (2,200 shares), Sell ABT (7,441 shares), Buy ABT (27,997 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | ABBOTT LABORATORIES (ABT) | EVP AND CFO | Sell | 388 | $42,820 |
| 2026-04-27 | ABBOTT LABORATORIES (ABT) | EVP AND CFO | Buy | 8,909 | $819,984 |
| 2026-04-27 | ABBOTT LABORATORIES (ABT) | EVP AND CFO | Buy | 2,200 | $201,300 |
| 2026-03-03 | ABBOTT LABORATORIES (ABT) | EVP AND CFO | Sell | 7,441 | $865,091 |
| 2026-02-26 | ABBOTT LABORATORIES (ABT) | EVP AND CFO | Buy | 27,997 | $0 |
| 2025-09-03 | ABBOTT LABORATORIES (ABT) | EVP AND CFO | Sell | 387 | $51,339 |
| 2025-08-11 | ABBOTT LABORATORIES (ABT) | EVP AND CFO | Sell | 5,550 | $746,752 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03